Callisto Pharmaceuticals' Other Investors

Callisto Pharmaceuticals raised a round of funding on , . Investors include Alta Partners.

Callisto Pharmaceuticals is a biopharmaceutical company focused on the development of drugs to treat multiple myeloma (an incurable blood cancer that invades and proliferates in bone marrow), and oste…

Articles about Callisto Pharmaceuticals' Other Investors: